Prophylaxis of Bleeding
Also known as: Prophylaxis of bleeding episodes
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB13884 | Albutrepenonacog alfa | A recombinant Factor IX fused to recombinant human albumin used to treat hemophilia B. |
| DB09329 | Antihemophilic factor (recombinant), PEGylated | For the management of hemophilia A (congenital factor VIII deficiency) [FDA label], . This medication is a human antihemophilic factor indicated in adolescent and adult patients (12 years and older)... |
| DB00025 | Antihemophilic factor, human recombinant | A form of recombinant coagulation Factor VIII used to treat hemophilia A, von Willebrand disease, and Factor XIII deficiency. |
| DB09310 | Catridecacog | A recombinant FXIII subunit‐A molecule evaluated for clotting factor replacement therapy in congenital FXIII deficiency. |
| DB00100 | Coagulation Factor IX (Recombinant) | A form of recombinant human coagulation Factor IX used to treat hemophilia B. |
| DB13148 | Coagulation factor X human | A coagulation factor used to treat Factor X deficiency to control bleeding. |
| DB00035 | Desmopressin | A synthetic analog of vasopressin used to reduce renal excretion of water in central diabetes insipidus and nocturia. |
| DB16662 | Efanesoctocog alfa | A recombinant DNA-derived, Factor VIII concentrate indicated for routine prophylaxis, on-demand treatment and control of bleeding episodes, and perioperative management of bleeding in patients with hemophilia A. |
| DB11607 | Efmoroctocog alfa | A recombinant Factor VIII used to treat and prevent bleeding in hemophilia A. |
| DB11330 | Factor IX Complex (Human) | A Factor IX complex used to prevent and treat bleeding episodes in hemophilia B or vitamin K antagonist therapy. |
| DB13998 | Lonoctocog alfa | A recombinant Factor VIII used to treat hemophilia A to control bleeding. |
| DB09109 | Turoctocog alfa | An antihemorrhagic agent used for the treatment and prophylaxis of bleeding in patients of all ages with haemophilia A (congenital factor VIII deficiency). |
| DB13133 | Von Willebrand factor human | A blood clotting factor used to manage bleeding episodes in von Willebrand disease and hemophilia A. |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB09329 | Antihemophilic factor (recombinant), PEGylated | 3 | Active Not Recruiting | 1 |
| DB14700 | Damoctocog alfa pegol | 3 | Active Not Recruiting | 1 |
| DB09329 | Antihemophilic factor (recombinant), PEGylated | 4 | Recruiting | 1 |
| DB14700 | Damoctocog alfa pegol | 4 | Recruiting | 1 |
| DB09329 | Antihemophilic factor (recombinant), PEGylated | Not Available | Recruiting | 2 |
| DB14700 | Damoctocog alfa pegol | Not Available | Recruiting | 2 |